Document is current
Any future updates will be listed below
-
Authors
Schaal, Jeffrey L.
Bhattacharyya, Jayanta
Brownstein, Jeremy
Strickland, Kyle C.
Kelly, Garrett
Saha, Soumen
Milligan, Joshua https://orcid.org/0000-0001-6370-1101
Banskota, Samagya
Li, Xinghai
Liu, Wenge
Kirsch, David G. https://orcid.org/0000-0002-2086-205X
Zalutsky, Michael R.
Chilkoti, Ashutosh https://orcid.org/0000-0002-1569-2228
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA197616)
- License Information
-
More Information
Article History
Received: 23 October 2019
Accepted: 6 September 2022
First Online: 19 October 2022
Competing interests
: A.C. is a scientific advisor to PhaseBio Pharmaceuticals, which has licensed the ELP technology for drug delivery from Duke University. D.G.K. is a co-founder of XRAD Therapeutics, which develops small-molecule radiosensitizers, and is on the Scientific Advisory Board of Lumicell, Inc., which commercializes intraoperative imaging technology. A provisional patent application (US20220008567A1, United States, 2018) has been filed by Duke University on the basis of this work, with J.L.S., A.C. and W.L. listed as inventors.
